Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Debt / NOTE 0.625% 4/0
-
Market price (% of par)
-
98.57%
-
Total 13F principal
-
$388,952,675
-
Principal change
-
-$12,064,011
-
Total reported market value
-
$383,102,487
-
Number of holders
-
41
-
Value change
-
-$11,850,144
-
Number of buys
-
15
-
Number of sells
-
18
Institutional Holders of SUPERNUS PHARMACEUTICALS INC - NOTE 0.625% 4/0 as of Q3 2021
As of 30 Sep 2021,
SUPERNUS PHARMACEUTICALS INC - NOTE 0.625% 4/0 was held by
41 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$388,952,675
in principal (par value) of the bond.
The largest 10 bondholders included
Radcliffe Capital Management, L.P., Opti Capital Management, LP, TENOR CAPITAL MANAGEMENT Co., L.P., CAMDEN ASSET MANAGEMENT L P /CA, JPMORGAN CHASE & CO, OAKTREE CAPITAL MANAGEMENT LP, DeepCurrents Investment Group LLC, AVIVA PLC, WOLVERINE ASSET MANAGEMENT LLC, and Invesco Ltd..
This page lists
41
institutional bondholders reporting positions
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.